Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01891318 : Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Have a prior histologic diagnosis of cancer other than small cell lung cancer,
lymphoma, and germ cell histologies

- Magnetic resonance imaging (MRI) evidence of 1-4 brain metastases, with at least one
lesion > 20 mm and = 50 mm in maximal diameter and determined to be appropriate for
SRS and gross total resection; all other brain metastases are appropriate for SRS

- Patient can have prior SRS to lesions other than the one planned for neoadjuvant SRS
and resection

- Patient must have a Karnofsky performance score of = 70

Exclusion Criteria:

- Patient deemed medically unfit to undergo surgical resection of brain metastasis

- Prior whole brain radiotherapy

- Patient with contraindication for imaging with MRI

- Inability to participate in study activities due to physical or mental limitations

- Inability or unwillingness to return for all the required follow-up visits

- At the time of planning, unable to deliver 10 Gray (Gy) or less to optic nerve/chiasm

- Tumor located in the brainstem

- Imaging or cytologic evidence of leptomeningeal disease
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557